A Peter Mac-led international clinical trial has found a way to personalize treatment for gastroesophageal cancer, identifying patients who could avoid further intensive rounds of chemotherapy while they recover from surgery. Each year more than 1,700 Australians are diagnosed with gastroesophageal cancer, which has a five-year survival rate of less than 25%.
Leave A Comment